Reaction

Pleuroparenchymal Fibroelastosis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 103 reports · 2 co-occurring drugs

As of the last recalculation, Pleuroparenchymal Fibroelastosis appears in 103 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is BLEOMYCIN SULFATE (PRR 370.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Bleomycin Sulfate	16	370.4	370.9
Ifosfamide	15	165.0	165.1

Related reactions

Drug Ineffective
Off Label Use
Death
Nausea
Fatigue

Data source: openFDA FAERS. See the OpenPV methodology and limitations.